Information on EC 2.3.1.180 - beta-ketoacyl-[acyl-carrier-protein] synthase III

Word Map on EC 2.3.1.180
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Specify your search results
Select one or more organisms in this record:
Show additional data
Do not include text mining results
Include (text mining) results (more...)
Include results (AMENDA + additional results, but less precise; more...)


The expected taxonomic range for this enzyme is: Eukaryota, Bacteria

EC NUMBER
COMMENTARY hide
2.3.1.180
-
RECOMMENDED NAME
GeneOntology No.
beta-ketoacyl-[acyl-carrier-protein] synthase III
REACTION
REACTION DIAGRAM
COMMENTARY hide
ORGANISM
UNIPROT
LITERATURE
acetyl-CoA + a malonyl-[acyl-carrier protein] = an acetoacetyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
Claisen condensation
-
PATHWAY
BRENDA Link
KEGG Link
MetaCyc Link
fatty acid biosynthesis initiation I
-
-
lipid metabolism
-
-
Fatty acid biosynthesis
-
-
Metabolic pathways
-
-
SYSTEMATIC NAME
IUBMB Comments
acetyl-CoA:malonyl-[acyl-carrier protein] C-acyltransferase
Involved in the dissociated (or type II) fatty-acid biosynthesis system that occurs in plants and bacteria. In contrast to EC 2.3.1.41 (beta-ketoacyl-ACP synthase I) and EC 2.3.1.179 (beta-ketoacyl-ACP synthase II), this enzyme specifically uses CoA thioesters rather than acyl-ACP as the primer [1]. In addition to the above reaction, the enzyme can also catalyse the reaction of EC 2.3.1.38, [acyl-carrier-protein] S-acetyltransferase, but to a much lesser extent [1]. The enzyme is responsible for initiating both straight- and branched-chain fatty-acid biosynthesis [2], with the substrate specificity in an organism reflecting the fatty-acid composition found in that organism [2,5]. For example, Streptococcus pneumoniae, a Gram-positive bacterium, is able to use both straight- and branched-chain (C4-C6) acyl-CoA primers [3] whereas Escherichia coli, a Gram-negative organism, uses primarily short straight-chain acyl CoAs, with a preference for acetyl-CoA [4,5].
CAS REGISTRY NUMBER
COMMENTARY hide
9077-10-5
-
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
gene fabH
UniProt
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
two isozymes KAS III-1 and KAS III-2
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
UniProt
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
strain L137, gene fabH
SwissProt
Manually annotated by BRENDA team
strain L137, gene fabH
SwissProt
Manually annotated by BRENDA team
-
UniProt
Manually annotated by BRENDA team
strain IL1403, gene fabH
-
-
Manually annotated by BRENDA team
strain IL1403, gene fabH
-
-
Manually annotated by BRENDA team
strain 10403S, gene fabH
UniProt
Manually annotated by BRENDA team
strain 10403S, gene fabH
UniProt
Manually annotated by BRENDA team
-
UniProt
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
SwissProt
Manually annotated by BRENDA team
strain D6
-
-
Manually annotated by BRENDA team
gene fabH
GenBank
Manually annotated by BRENDA team
gene fabH
GenBank
Manually annotated by BRENDA team
-
UniProt
Manually annotated by BRENDA team
strain A3(2), gene fabH
SwissProt
Manually annotated by BRENDA team
gene dpsC
-
-
Manually annotated by BRENDA team
-
UniProt
Manually annotated by BRENDA team
strain Xoo KACC10331, gene fabH or Xoo4209
-
-
Manually annotated by BRENDA team
strain Xoo KACC10331, gene fabH or Xoo4209
-
-
Manually annotated by BRENDA team
gene fabH
UniProt
Manually annotated by BRENDA team
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
evolution
metabolism
physiological function
additional information
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
2-methylbutyryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-4-methyl-hexanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
2-methylbutyryl-CoA is the preferred primer substrate of isozyme FabH1
-
-
?
2-methylbutyryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-4-methylhexanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
2-methylcrotonyl-CoA + malonyl-[acyl-carrier protein]
(4E)-4-methylhex-4-enoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
-
-
-
?
3-oxoacyl-ACP + acetyl-CoA
acetyl-ACP + 3-ketoacyl-CoA
show the reaction diagram
-
-
-
-
?
acetoacetyl-ACP + acetyl-CoA
acetyl-ACP + acetoacetyl-CoA
show the reaction diagram
-
-
-
-
?
acetyl-CoA + a malonyl-[acyl-carrier protein]
an acetoacetyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
acetyl-CoA + ACP
acetyl-ACP + CoA
show the reaction diagram
acetyl-CoA:ACP transacylase activity
-
-
?
acetyl-CoA + malonyl-ACP
acetoacetyl-ACP + CoA + CO2
show the reaction diagram
acetyl-CoA + malonyl-[acyl-carrier protein]
3-oxopropionyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
acetyl-CoA + malonyl-[acyl-carrier protein]
acetoacetyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
acetyl-CoA + [acyl-carrier protein]
acetyl-[acyl-carrier protein] + CoA
show the reaction diagram
the enzyme also shows acetyltransferase activity
-
-
?
acyl-CoA + malonyl-[acyl-carrier protein]
acetoacyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
arachidoyl-CoA + malonyl-[acyl-carrier protein]
3-oxo-docosanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
low activity
-
-
?
butyryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-hexanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
butyryl-CoA + malonyl-[acyl-carrier protein]
3-oxohexanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
-
-
?
decanoyl-CoA + malonyl-[acyl-carrier protein]
3-oxo-lauroyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
-
-
-
?
heptanoyl-CoA + malonyl-[acyl-carrier protein]
3-oxo-nonanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
-
-
-
?
hexanoyl-CoA + malonyl-[acyl-carrier protein]
3-oxo-octanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
isobutyryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-4-methyl-pentanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
isobutyryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-4-methylpentanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
-
-
?
isovaleryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-5-methyl-hexanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
isovaleryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-5-methylhexanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
-
-
?
lauroyl-CoA + malonyl-[acyl-carrier protein]
3-oxo-myristoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
malonyl-ACP + acetyl-CoA
CO2 + CoA + acetoacetyl-ACP
show the reaction diagram
malonyl-ACP + acyl-CoA
3-oxoacyl-ACP + CoA + CO2
show the reaction diagram
specificity for branched acyl-CoA substrate
-
-
?
malonyl-ACP + acyl-CoA
CO2 + CoA + ?
show the reaction diagram
-
-
-
?
myristoyl-CoA + malonyl-[acyl-carrier protein]
3-oxo-palmitoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
octanoyl-CoA + malonyl-[acyl-carrier protein]
3-oxo-decanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
palmitoyl-CoA + malonyl-[acyl-carrier protein]
3-oxo-stearoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
propionyl-CoA + malonyl-[acyl-carrier protein]
3-oxo-valeryl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
stearoyl-CoA + malonyl-[acyl-carrier protein]
3-oxo-arachidoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
low activity
-
-
?
valeryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-heptanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
-
-
-
?
additional information
?
-
NATURAL SUBSTRATES
NATURAL PRODUCTS
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
2-methylbutyryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-4-methylhexanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
acetyl-CoA + a malonyl-[acyl-carrier protein]
an acetoacetyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
acetyl-CoA + malonyl-[acyl-carrier protein]
3-oxopropionyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
acetyl-CoA + malonyl-[acyl-carrier protein]
acetoacetyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
acyl-CoA + malonyl-[acyl-carrier protein]
acetoacyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
butyryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-hexanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
-
-
-
?
butyryl-CoA + malonyl-[acyl-carrier protein]
3-oxohexanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
C0LNR0
-
-
-
?
isobutyryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-4-methyl-pentanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
-
-
-
?
isobutyryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-4-methylpentanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
C0LNR0
-
-
-
?
isovaleryl-CoA + malonyl-[acyl-carrier protein]
3-oxo-5-methylhexanoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
C0LNR0
-
-
-
?
myristoyl-CoA + malonyl-[acyl-carrier protein]
3-oxo-palmitoyl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
the enzyme plays a key role in initiation of the long-chain fatty acid route of meromycolic acid biosynthesis, a different enzyme with specificity for short-chain acyl-CoAs might also be responsible for meromycolic acid biosynthesis, biosynthetic pathway regulation mechanism
-
-
?
propionyl-CoA + malonyl-[acyl-carrier protein]
3-oxo-valeryl-[acyl-carrier protein] + CoA + CO2
show the reaction diagram
-
the enzyme specifies the propionate-starter unit for type II polyketide biosynthesis
-
-
?
additional information
?
-
COFACTOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
acetyl-CoA
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
Mg2+
-
required
INHIBITORS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(2R)-5-hydroxy-2,4-dimethyl-2-[(1E)-2-methylbuta-1,3-dien-1-yl]thiophen-3(2H)-one
-
-
(5R)-4-hydroxy-3,5-dimethyl-5-tetradecylthiophen-2(5H)-one
-
-
(5R)-4-hydroxy-3,5-dimethyl-5-tridecylthiophen-2(5H)-one
-
-
(5R)-4-hydroxy-5-[[4'-(hydroxymethyl)biphenyl-4-yl]methyl]-3,5-dimethylthiophen-2(5H)-one
-
-
(5R)-5-dodecyl-4-hydroxy-3,5-dimethylthiophen-2(5H)-one
-
-
(5R)-5-[3-(4-acetyl-3-hydroxyphenyl)prop-2-yn-1-yl]-4-hydroxy-3,5-dimethylthiophen-2(5H)-one
-
-
(5R)-5-[3-(4-acetylphenyl)prop-2-yn-1-yl]-4-hydroxy-3,5-dimethylthiophen-2(5H)-one
-
-
(9E)-N-[(4-aminophenyl)sulfonyl]undec-9-enamide
-
-
(E) -N'-((E)-3-(2-methoxyphenyl)al lyl idene)-2,3-dihydrobenzo[b][1,4]dioxine-2-carbohydrazide
-
-
(E) -N'-((E)-3-(2-Ni trophenyl)allylidene)-2,3-dihydrobenzo[b][1,4]dioxine-2-carbohydrazide
(E) -N'-((E)-3-(4-bromophenyl)al lyl idene)-2,3-dihydrobenzo[b][1,4]dioxine-2-carbohydrazide
-
-
(E) -N'-((E)-3-(4-bromophenyl)allylidene)-2,3-dihydrobenzo[b][1,4]dioxine-2-carbohydrazide
-
-
(E)-1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-yl 3-(2,4-dichlorophenyl)acrylate
-
-
(E)-1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-yl 3-(2-bromophenyl)acrylate
-
-
(E)-1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-yl 3-(3-bromophenyl)acrylate
-
-
(E)-1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-yl 3-(3-fluorophenyl)acrylate
-
-
(E)-1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-yl 3-(4-(benzyloxy)phenyl)acrylate
-
-
(E)-1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-yl 3-(4-(dimethylamino)phenyl)acrylate
-
-
(E)-1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-yl 3-(4-bromophenyl)acrylate
-
-
(E)-1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-yl 3-(4-chlorophenyl)acrylate
-
-
(E)-1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-yl 3-(biphenyl-4-yl)acrylate
-
-
(E)-1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-yl 3-(naphthalen-1-yl)acrylate
-
-
(E)-2-(2,6-dimethylphenyl)ethenyl phenyl sulfone
-
-
(E)-ethyl 2-(4-(benzyloxy)phenyl)-3-(4-bromophenylamino)acrylate
-
-
(E)-ethyl 2-(4-(benzyloxy)phenyl)-3-(4-isopropylphenylamino)acrylate
-
-
(E)-N'-((E)-3-(2-fluorophenyl)allyl idene)-2,3-dihydrobenzo[b][1,4]dioxine-2-carbohydrazide
-
-
-
(E)-N'-((E)-3-(2-fluorophenyl)allylidene)-2,3-dihydrobenzo[b][1,4]dioxine-2-carbohydrazide
-
(E)-N'-((E)-3-(2-methoxyphenyl)allyl idene)-2,3-dihydrobenzo[b][1,4]dioxine-2-carbohydrazide
-
-
-
(E)-N'-((E)-3-(2-methoxyphenyl)allylidene)-2,3-dihydrobenzo[b][1,4]dioxine-2-carbohydrazide
-
(E)-N'-((E)-3-(2-Ni trophenyl)allylidene)-2,3-dihydrobenzo[b][1,4]dioxine-2-carbohydrazide
-
-
(E)-N'-((E)-3-(2-nitrophenyl)allylidene)-2,3-dihydrobenzo[b][1,4]dioxine-2-carbohydrazide
-
-
(E)-N'-((E)-3-(4-bromophenyl)allylidene)-2,3-dihydrobenzo[b][1,4]dioxine-2-carbohydrazide
-
(E)-N'-((E)-3-phenylallylidene)-2,3-dihydrobenzo[b][1,4]-dioxine-2-carbohydrazide
(Z)-1-methyl-2-phenylethenyl phenyl sulfone
-
-
(Z)-ethyl 2-(4-(benzyloxy)phenyl)-3-(2,4-dibromophenylamino)acrylate
-
-
(Z)-ethyl 2-(4-(benzyloxy)phenyl)-3-(2-chlorophenylamino)acrylate
-
-
(Z)-ethyl 2-(4-(benzyloxy)phenyl)-3-(4-bromophenylamino)acrylate
-
-
(Z)-ethyl 2-(4-(benzyloxy)phenyl)-3-(4-fluorophenylamino)acrylate
-
-
(Z)-ethyl 3-(p-toluidino)-2-(4-(benzyloxy)phenyl)acrylate
-
-
1,1'-disulfanediyldinaphthalen-2-ol
-
-
1-(2,6-dichlorobenzyl)-5-[(3-methoxybenzyl)oxy]-1H-indole-2-carboxylic acid
-
1-(2,6-dichlorobenzyl)-5-[[2-fluoro-6-(trifluoromethyl)benzyl]oxy]-1H-indole-2-carboxylic acid
-
1-(2,6-dichlorobenzyl)-5-[[4-(trifluoromethyl)benzyl]oxy]-1H-indole-2-carboxylic acid
an indole derivative, inhibits FabH by 98% at 0.0375 mM
1-(2-bromobenzyl)-5-[(3-methoxybenzyl)oxy]-1H-indole-2-carboxylic acid
-
1-(2-chlorophenyl)-1-(3,5-dibromo-2-hydroxybenzyl)-3-phenylurea
-
-
1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-yl (2E)-3-(biphenyl-4-yl)prop-2-enoate
-
-
1-(3,5-dibromo-2-hydroxybenzyl)-1-(4-fluorophenyl)-3-phenylurea
-
-
1-(4-carboxybenzyl)-5-[[2-fluoro-6-(trifluoromethyl)benzyl]oxy]-1H-indole-2-carboxylic acid
an indole derivative, inhibits FabH by 80% at 0.040 mM
1-(4-carboxybutyl)-5-[(2,6-dichlorobenzyl)oxy]-1H-indole-2-carboxylic acid
1-(4-chlorophenyl)-1-(3,5-dibromo-2-hydroxybenzyl)-3-phenylurea
-
-
1-(4-[(E)-[3-(benzyloxy)benzylidene]amino]phenyl)-3-phenylthiourea
-
molecular docking indicates that the compound has one hydrogen bonding interaction with Thr 81 of Escherichia coli FabH
1-(5-bromo-2-hydroxybenzyl)-1-(2-bromophenyl)-3-phenylurea
-
-
1-(5-bromo-2-hydroxybenzyl)-1-(2-chlorophenyl)-3-phenylurea
-
-
1-(5-bromo-2-hydroxybenzyl)-1-(2-fluorophenyl)-3-phenylurea
-
-
1-(5-bromo-2-hydroxybenzyl)-1-(4-bromophenyl)-3-phenylurea
-
-
1-(5-bromo-2-hydroxybenzyl)-1-(4-chlorophenyl)-3-phenylurea
-
-
1-(5-bromo-2-hydroxybenzyl)-1-(4-fluorophenyl)-3-phenylurea
-
-
1-(5-carboxypentyl)-5-[(2,6-dichlorobenzyl)oxy]-1H-indole-2-carboxylic acid
-
-
1-(5-carboxypentyl)-5-[[2-fluoro-6-(trifluoromethyl)benzyl]oxy]-1H-indole-2-carboxylic acid
-
1-cyclohexyl-N-(2'-hydroxy-1,1':3',1''-terphenyl-5'-yl)-5-oxopyrrolidine-3-carboxamide
-
-
1-phenylethyl (2Z)-3-[(4,5-dimethyl-2-oxido-1,3,2-dioxaphospholan-2-yl)oxy]but-2-enoate
-
-
1-[(6-chloro-1,3-benzodioxol-5-yl)methyl]-5-[(2,6-dichlorobenzyl)oxy]-1H-indole-2-carboxylic acid
1-[3,5-bis(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone
-
-
1-[3-(4-methoxyphenyl)-5-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone
-
-
1-[3-(4-methoxyphenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl]ethanone
-
-
1-[4-(trifluoromethyl)benzyl]-5-[[4-(trifluoromethyl)benzyl]oxy]-1H-indole-2-carboxylic acid
-
1-[5-(2-chlorophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone
-
-
1-[5-(4-bromophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone
-
-
1-[5-(4-chlorophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone
-
-
1-[5-(4-fluorophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone
-
-
14-bromo-3-diethylsulfamoyl-5-methylbenzoic acid
-
-
2,2'-(benzene-1,3-diyldisulfonyl)dibenzene-1,4-diol
-
-
2,2'-disulfanediylbis(4-chlorophenol)
-
-
2,2'-disulfanediyldiphenol
-
-
2,2'-sulfanediylbis(4-chlorophenol)
-
-
2,2'-trisulfane-1,3-diylbis(4-chlorophenol)
-
-
2,4-dibromo-6-[(E)-[(4-phenyl-1,3-thiazol-2-yl)hydrazono]methyl]phenol
-
-
2,4-dibromo-6-[(E)-[2-[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]hydrazinylidene]methyl]phenol
-
the binding model demonstrated that the phenolic hydroxy group of 40 interacts with the amino hydrogen of Asn247 of Escherichia coli FabH by hydrogen bonds
2,4-dibromo-6-[(E)-[[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]hydrazono]methyl]phenol
-
-
2,4-dibromo-6-[(E)-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]hydrazono]methyl]phenol
-
-
2,4-dichloro-6-[(E)-[(4-phenyl-1,3-thiazol-2-yl)hydrazono]methyl]phenol
-
-
2,4-dichloro-6-[(E)-[[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]hydrazono]methyl]phenol
-
-
2,4-dichloro-6-[(E)-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]hydrazono]methyl]phenol
-
-
2,5-anhydro-3,4-dideoxy-3-[[(3-phenoxyphenyl)carbonyl]amino]-2-thiopentonic acid
2,5-dichloro-4-nitro-N-[4-(trifluoromethyl)phenyl]thiophene-3-sulfonamide
-
-
2,5-dichloro-N-[4-(trifluoromethyl)phenyl]thiophene-3-sulfonamide
-
-
2-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-5-(2-methylbenzyl)-1,3,4-oxadiazole
-
-
2-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-5-(4-nitrophenyl)-1,3,4-oxadiazol
-
-
2-((4-bromo-3-[(diethylamino)sulfonyl]benzoyl)amino)benzoic acid
benzoylamino-benzoic acid derivative inhibitor-enzyme interaction analysis, overview
-
2-(2-methoxyphenyl)-5-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1,3,4-oxadiazole
-
-
2-(2-methoxyphenyl)-5-[(2-methyl-5-nitro-1H-imidazol-1-yl)methyl]-1,3,4-oxadiazole
-
-
2-(3,4-diethoxyphenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide
-
-
2-(3-bromobenzoylamino)benzoic acid methyl ester
-
-
2-(3-bromophenyl)-5-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1,3,4-oxadiazole
-
-
2-(3-bromophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide
-
-
2-(3-bromophenyl)-N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]acetamide
-
-
2-(3-chlorophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide
-
-
2-(3-diethylsulfamoyl-4-fluorobenzoylamino)benzoic acid
-
IC50 is 0.0084 mM
2-(3-diethylsulfamoyl-4-methoxybenzoylamino)benzoic acid
-
IC50 is 0.0114 mM
2-(3-diethylsulfamoyl-4-phenoxybenzoylamino)benzoic acid
-
IC50 is 0.0061 mM
2-(3-diethylsulfamoyl-4-piperidin-1-ylbenzoylamino)benzoic acid
-
IC50 is 0.0022 mM
2-(3-methoxyphenyl)-5-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1,3,4-oxadiazole
-
-
2-(3-methoxyphenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide
-
-
2-(3-phenoxy-4-piperazin-1-ylbenzoylamino)benzoic acid
-
IC50 is 0.185 mM
2-(3-phenoxy-4-piperidin-1-ylbenzoylamino)benzoic acid
-
IC50 is 0.00029 mM
2-(3-phenoxy-4-pyridin-3-ylbenzoylamino)benzoic acid
-
IC50 is 0.00011 mM
2-(3-phenoxy-4-thiomorpholin-4-ylbenzoylamino)benzoic acid
-
IC50 is 0.0012 mM
2-(3-phenoxybenzoylamino)benzoic acid
-
IC50 is 0.0027 mM
2-(3-phenoxybenzoylamino)nicotinic acid
-
IC50 is above 1.0 mM
2-(3-phenoxybenzoylamino)thiophene-3-carboxylic acid
-
IC50 is 0.043 mM
2-(4-bromo-3-diethylsulfamoyl-5-methylbenzoylamino)-benzoic acid
-
IC50 is 0.16 mM
2-(4-bromo-3-diethylsulfamoylbenzoylamino)-benzoic acid
-
IC50 is 0.0016 mM
2-(4-bromo-3-phenoxybenzoylamino)-6-hydroxybenzoic acid
-
IC50 is 0.000062 mM
2-(4-bromo-3-phenoxybenzoylamino)-6-methoxybenzoic acid
-
-
2-(4-bromo-3-phenoxybenzoylamino)benzoic acid
-
IC50 is 0.0011 mM
2-(4-bromo-3-phenoxybenzoylamino)benzoic acid methyl ester
-
-
2-(4-bromophenyl)-5-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1,3,4-oxadiazole
-
-
2-(4-bromophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide
-
-
2-(4-bromophenyl)-N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]acetamide
-
-
2-(4-chlorophenyl)-5-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1,3,4-oxadiazole
-
-
2-(4-chlorophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide
-
-
2-(4-cyclopentylmethoxy-3-diethylsulfamoylbenzoylamino)benzoic acid
-
IC50 is 0.0021 mM
2-(4-fluoro-3-phenoxybenzoylamino)benzoic acid
-
IC50 is 0.0038 mM
2-(4-fluoro-3-phenoxybenzoylamino)benzoic acid methyl ester
-
-
2-(4-fluorophenyl)-5-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1,3,4-oxadiazole
-
-
2-(4-fluorophenyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide
-
-
2-(4-morpholin-4-yl-3-phenoxybenzoylamino)benzoic acid
-
IC50 is 0.0032 mM
2-(butylsulfonyl)ethyl 4-nitrobenzoate
-
-
2-(tert-butylsulfonyl)-1-(2,4-dichlorophenyl)ethanone
-
-
2-([3-[(diethylamino)sulfonyl]-4-fluorobenzoyl]amino)benzoic acid
-
-
2-([3-[(diethylamino)sulfonyl]-4-methoxybenzoyl]amino)benzoic acid
-
-
2-([4-bromo-3-[(diethylamino)sulfonyl]-5-methylbenzoyl]amino)benzoic acid
-
-
2-([4-bromo-3-[(diethylamino)sulfonyl]benzoyl]amino)benzoic acid
-
-
2-([[2-(diethylsulfamoyl)biphenyl-4-yl]carbonyl]amino)benzoic acid
-
-
2-([[2-(diethylsulfamoyl)biphenyl-4-yl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[2-phenoxy-3'-(trifluoromethoxy)biphenyl-4-yl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[2-phenoxy-4'-(trifluoromethyl)biphenyl-4-yl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[3'-(1-methylethyl)-2-phenoxybiphenyl-4-yl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[3-(4-fluorophenoxy)phenyl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[3-(diethylsulfamoyl)-4-fluorophenyl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[3-(diethylsulfamoyl)-4-methoxyphenyl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[3-(diethylsulfamoyl)-4-phenoxyphenyl]carbonyl]amino)benzoic acid
-
-
2-([[3-(diethylsulfamoyl)-4-phenoxyphenyl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[3-(diethylsulfamoyl)-4-piperidin-1-ylphenyl]carbonyl]amino)benzoic acid
-
-
2-([[3-(diethylsulfamoyl)-4-piperidin-1-ylphenyl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[3-(pyridin-2-yloxy)phenyl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[3-phenoxy-4-(1H-pyrazol-4-yl)phenyl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[4'-(methylsulfonyl)-2-phenoxybiphenyl-4-yl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[4-(3,5-dimethylpiperazin-1-yl)-3-phenoxyphenyl]carbonyl]amino)benzoic acid
-
-
2-([[4-(3,5-dimethylpiperidin-1-yl)-3-phenoxyphenyl]carbonyl]amino)benzoic acid
2-([[4-(3,5-dimethylpiperidin-1-yl)-3-phenoxyphenyl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[4-(4-methylpiperazin-1-yl)-3-phenoxyphenyl]carbonyl]amino)benzoic acid
-
-
2-([[4-(cyclopentylmethoxy)-3-(diethylsulfamoyl)phenyl]carbonyl]amino)benzoic acid
-
-
2-([[4-(cyclopentylmethoxy)-3-(diethylsulfamoyl)phenyl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[4-bromo-3-(diethylsulfamoyl)-5-methylphenyl]carbonyl]amino)cyclohexanecarboxylic acid
2-([[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl]amino)cyclohexanecarboxylic acid
2-amino-5-(3-chlorophenyl)thiazole-4-carboxylic acid
MIC value is 0.125 mM
2-amino-5-methylthiazole-4-carboxylic acid
MIC value is 0.00035 mM
2-amino-6-(naphthalen-2-ylsulfonyl)quinazolin-4-ol
-
-
2-chloro-4-sulfanylphenol
-
-
2-fluoro-6-(3-phenoxybenzoylamino)benzoic acid
-
IC50 is 0.006 mM
2-fluoro-6-[(3-phenoxybenzoyl)amino]benzoic acid
-
-
2-hydroxy-4-[(phenylsulfonyl)amino]benzoic acid
-
-
2-hydroxy-6-(3-phenoxybenzoylamino)benzoic acid
-
IC50 is 0.00041 mM
2-hydroxy-6-[(2-phenoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.000004 mM
2-hydroxy-6-[(3-phenoxybenzoyl)amino]benzoic acid
-
-
2-hydroxy-6-[[(2-phenoxybiphenyl-4-yl)carbonyl]amino]benzoic acid
2-phenyl-N-(4-phenyl-1,3-thiazol-2-yl)acetamide
-
-
2-[(2',4'-difluoro-2-phenoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.00016 mM
2-[(2-diethylsulfamoyl-biphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.0016 mM
2-[(2-phenoxy-3'-trifluoromethoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.00047 mM
2-[(2-phenoxy-4'-trifluoromethylbiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.000096 mM
2-[(2-phenoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.000056 mM
2-[(2E)-2-[(4-bromophenyl)methylidene]hydrazino]-4-(3,4-dichlorophenyl)-1,3-thiazole
-
-
2-[(2E)-2-[(4-bromophenyl)methylidene]hydrazino]-4-(4-chlorophenyl)-1,3-thiazole
-
-
2-[(2E)-2-[(4-bromophenyl)methylidene]hydrazino]-4-phenyl-1,3-thiazole
-
-
2-[(2E)-2-[(4-chlorophenyl)methylidene]hydrazino]-4-(3,4-dichlorophenyl)-1,3-thiazole
-
-
2-[(2E)-2-[(4-chlorophenyl)methylidene]hydrazino]-4-phenyl-1,3-thiazole
-
-
2-[(2E)-2-[(4-fluorophenyl)methylidene]hydrazino]-4-phenyl-1,3-thiazole
-
-
2-[(2E)-2-[(4-methoxyphenyl)methylidene]hydrazino]-4-phenyl-1,3-thiazole
-
-
2-[(2E)-2-[(4-methylphenyl)methylidene]hydrazino]-4-phenyl-1,3-thiazole
-
-
2-[(3',4'-difluoro-2-phenoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.00033 mM
2-[(3'-chloro-4'-fluoro-2-phenoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.00057 mM
2-[(3'-isopropyl-2-phenoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.00079 mM
2-[(3-phenoxy-4-pyridin-3-ylbenzoyl)amino]benzoic acid
-
-
2-[(3-phenoxybenzoyl)amino]benzoic acid
-
-
2-[(3-phenoxybenzoyl)amino]thiophene-3-carboxylic acid
-
-
2-[(4'-chloro-3'-methyl-2-phenoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.00025 mM
2-[(4'-ethoxy-2-phenoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.00022 mM
2-[(4'-fluoro-3'-methyl-2-phenoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.00024 mM
2-[(4'-hydroxy-2-phenoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.00041 mM
2-[(4'-methanesulfonyl-2-phenoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.000028 mM
2-[(4'-methyl-2-phenoxybiphenyl-4-carbonyl)amino]benzoic acid
-
IC50 is 0.00016 mM
2-[(4-aminocyclohexyl)sulfonyl]naphthalene-1,4-diol
-
-
2-[(4-aminophenyl)sulfonyl]benzene-1,4-diol
-
-
2-[(4-bromo-3-phenoxybenzoyl)amino]-6-hydroxybenzoic acid
-
-
2-[(4-bromo-3-phenoxybenzoyl)amino]benzoic acid
-
-
2-[(4-fluoro-3-phenoxybenzoyl)amino]benzoic acid
-
-
2-[(4-methylphenyl)sulfonyl]benzene-1,4-diol
-
-
2-[(4-methylphenyl)sulfonyl]naphthalene-1,4-diol
-
-
2-[([4-[(3,5-dimethylpiperazin-1-yl)methyl]-3-phenoxyphenyl]carbonyl)amino]cyclohexanecarboxylic acid
2-[([4-[(4-methylpiperazin-1-yl)methyl]-3-phenoxyphenyl]carbonyl)amino]cyclohexanecarboxylic acid
2-[3-(3,4-dichlorophenyl)-5-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]-4-phenyl-1,3-thiazole
-
-
2-[3-(3-carboxyphenoxy)benzoylamino]benzoic acid
-
IC50 is 0.0037 mM
2-[3-(4-bromophenyl)-5-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]-4-(4-methoxyphenyl)-1,3-thiazole
-
-
2-[3-(4-bromophenyl)-5-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]-4-phenyl-1,3-thiazole
-
-
2-[3-(4-bromophenyl)-5-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]-1,3-thiazol-4(5H)-one
-
-
2-[3-(4-bromophenyl)-5-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]-4-phenyl-1,3-thiazole
-
-
2-[3-(4-carboxyphenoxy)benzoylamino]benzoic acid
-
IC50 is 0.0044 mM
2-[3-(4-fluorophenoxy)benzoylamino]benzoic acid
-
IC50 is 0.005 mM
2-[3-(4-fluorophenyl)-5-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]-1,3-thiazol-4(5H)-one
-
-
2-[3-(4-fluorophenyl)-5-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]-4-phenyl-1,3-thiazole
-
-
2-[3-(4-methoxyphenyl)-5-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]-1,3-thiazol-4(5H)-one
-
-
2-[3-(4-methoxyphenyl)-5-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]-4-phenyl-1,3-thiazole
-
-
2-[3-(4-methylphenyl)-5-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]-1,3-thiazol-4(5H)-one
-
-
2-[3-(4-methylphenyl)-5-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]-4-phenyl-1,3-thiazole
-
-
2-[3-(pyridin-4-yloxy)benzoylamino]benzoic acid
-
IC50 is 0.010 mM
2-[3-phenoxy-4-(1H-pyrazol-4-yl)benzoylamino]benzoic acid
-
IC50 is 0.022 mM
2-[4-(2,4-dinitrophenyl)-1H-pyrazol-1-yl]-4-(trifluoromethyl)pyrimidine
-
-
2-[4-(3,5-dimethylpiperazin-1-yl)-3-phenoxybenzoylamino]benzoic acid
-
IC50 is 0.038 mM
2-[4-(3,5-dimethylpiperidin-1-yl)-3-phenoxybenzoylamino]benzoic acid
-
IC50 is 0.00027 mM
2-[4-(4-methylpiperazin-1-yl)-3-phenoxybenzoylamino]benzoic acid
-
IC50 is 0.025 mM
2-[4-[3-bromo-4-(hydroxymethyl)phenyl]piperazin-1-yl]-1-(5-nitrofuran-2-yl)ethanone
-
-
2-[5-(furan-2-yl)-3-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-1,3-thiazol-4(5H)-one
-
-
2-[5-(furan-2-yl)-3-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-(4-methoxyphenyl)-1,3-thiazole
-
-
2-[5-(furan-2-yl)-3-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-phenyl-1,3-thiazole
-
-
2-[5-(furan-2-yl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl]-1,3-thiazol-4(5H)-one
-
-
2-[[(2',4'-difluoro-2-phenoxybiphenyl-4-yl)carbonyl]amino]benzoic acid
-
-
2-[[(2',4'-difluoro-2-phenoxybiphenyl-4-yl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(2-hydroxy-6-phenoxybiphenyl-4-yl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(2-phenoxybiphenyl-4-yl)carbonyl]amino]benzoic acid
-
-
2-[[(2-phenoxybiphenyl-4-yl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(3',4'-difluoro-2-phenoxybiphenyl-4-yl)carbonyl]amino]benzoic acid
-
-
2-[[(3',4'-difluoro-2-phenoxybiphenyl-4-yl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(3'-chloro-4'-fluoro-2-phenoxybiphenyl-4-yl)carbonyl]amino]benzoic acid
-
-
2-[[(3'-chloro-4'-fluoro-2-phenoxybiphenyl-4-yl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(3-phenoxy-4-piperazin-1-ylphenyl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(3-phenoxy-4-piperidin-1-ylphenyl)carbonyl]amino]benzoic acid
2-[[(3-phenoxy-4-piperidin-1-ylphenyl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(3-phenoxy-4-pyridin-3-ylphenyl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(3-phenoxy-4-thiomorpholin-4-ylphenyl)carbonyl]amino]benzoic acid
2-[[(3-phenoxy-4-thiomorpholin-4-ylphenyl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(3-phenoxyphenyl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(3-phenoxyphenyl)carbonyl]amino]piperidine-3-carboxylic acid
2-[[(3-phenoxyphenyl)carbonyl]amino]tetrahydrothiophene-3-carboxylic acid
2-[[(4'-chloro-3'-methyl-2-phenoxybiphenyl-4-yl)carbonyl]amino]benzoic acid
-
-
2-[[(4'-chloro-3'-methyl-2-phenoxybiphenyl-4-yl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(4'-ethoxy-2-phenoxybiphenyl-4-yl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(4'-fluoro-3'-methyl-2-phenoxybiphenyl-4-yl)carbonyl]amino]-6-hydroxybenzoic acid
2-[[(4'-fluoro-3'-methyl-2-phenoxybiphenyl-4-yl)carbonyl]amino]benzoic acid
-
-
2-[[(4'-fluoro-3'-methyl-2-phenoxybiphenyl-4-yl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(4'-hydroxy-2-phenoxybiphenyl-4-yl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(4'-methyl-2-phenoxybiphenyl-4-yl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(4-bromo-3-hydroxy-5-phenoxyphenyl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(4-bromo-3-phenoxyphenyl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(4-fluoro-3-phenoxyphenyl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(4-hydroxy-3-phenoxyphenyl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[(4-morpholin-4-yl-3-phenoxyphenyl)carbonyl]amino]benzoic acid
-
-
2-[[(4-morpholin-4-yl-3-phenoxyphenyl)carbonyl]amino]cyclohexanecarboxylic acid
2-[[3-(3-carboxyphenoxy)benzoyl]amino]benzoic acid
-
-
2-[[3-(4-carboxyphenoxy)benzoyl]amino]benzoic acid
-
-
2-[[3-(4-fluorophenoxy)benzoyl]amino]benzoic acid
-
-
2-[[3-(pyridin-4-yloxy)benzoyl]amino]benzoic acid
-
-
2-[[3-phenoxy-4-(1H-pyrazol-4-yl)benzoyl]amino]benzoic acid
-
-
3,6-dihydroxyflavone
-
i.e. YKAF01
3-(2-phenylethyl)-1,3-thiazolidin-2-one 1,1-dioxide
3-(2-phenylethyl)-1,3-thiazolidine-2-thione
3-(3-phenoxybenzoylamino)pyridine-2-carboxylic acid
-
IC50 is 0.290 mM
3-(3-phenoxybenzoylamino)thiophene-2-carboxylic acid
-
IC50 is 0.0101 mM
3-(4-hydroxyphenyl)-1-(2,4,6-tri-hydroxyphenyl)propan-1-one
-
i.e. YKAF04, or 4,2',4',6'-tetrahydroxychalcone, or phloretin
3-(4-phenoxybenzyl)-1,3-thiazolidin-2-one
3-(4-phenoxybenzyl)-1,3-thiazolidin-2-one 1,1-dioxide
3-(4-phenoxybenzyl)-1,3-thiazolidine-2-thione
-
-
3-(biphenyl-4-ylmethyl)-1,3-thiazolidin-2-one
3-(biphenyl-4-ylmethyl)-1,3-thiazolidin-2-one 1,1-dioxide
3-(biphenyl-4-ylmethyl)-1,3-thiazolidine-2-thione
3-(pyridin-3-ylmethyl)-1,3-thiazolidin-2-one
3-(pyridin-3-ylmethyl)-1,3-thiazolidine-2-thione
3-benzyl-1,3-thiazolidin-2-one
3-benzyl-1,3-thiazolidin-2-one 1,1-dioxide
3-benzyl-1,3-thiazolidine-2-thione
3-bromo-N-(4-phenyl-1,3-thiazol-2-yl)benzamide
-
-
3-bromo-N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]benzamide
-
fitting 3-bromo-N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]benzamide into the active site of Escherichia coli FabH,PDB ID 3IL9
3-chloro-N-(4-phenyl-1,3-thiazol-2-yl)benzamide
-
-
3-diethylsulfamoyl-4-fluorobenzoic acid
-
-
3-diethylsulfamoyl-4-methoxybenzoic acid
-
-
3-ethoxy-N-(4-phenyl-1,3-thiazol-2-yl)benzamide
-
-
3-methoxy-N-(4-phenyl-1,3-thiazol-2-yl)benzamide
-
-
3-methyl-1,3-thiazolidin-2-one 1,1-dioxide
3-methyl-1,3-thiazolidine-2-thione
3-propyl-1,3-thiazolidin-2-one 1,1-dioxide
3-propyl-1,3-thiazolidine-2-thione
3-[(1E)-N-(4-methyl-1,3-thiazol-2-yl)ethanehydrazonoyl]phenol
-
i.e. YKA3003
3-[(3-phenoxybenzoyl)amino]thiophene-2-carboxylic acid
-
-
3-[(4'-cyclopentylbiphenyl-4-yl)methyl]-1,3-thiazolidin-2-one 1,1-dioxide
3-[(4-aminophenyl)sulfonyl]-5-methylbenzene-1,2-diol
-
-
3-[2-(3,4-dihydroxyphenyl)-1-methyl-2-oxoethyl]-6,7-dimethoxy-2-benzofuran-1(3H)-one
-
i.e. YKA3001
3-[3-[(2-carboxycyclohexyl)carbamoyl]phenoxy]benzoic acid
3-[4-(4-cyclopentylphenoxy)benzyl]-1,3-thiazolidin-2-one
3-[4-(4-cyclopentylphenoxy)benzyl]-1,3-thiazolidin-2-one 1,1-dioxide
3-[4-(4-cyclopentylphenoxy)benzyl]-1,3-thiazolidine-2-thione
3-[[(3-phenoxyphenyl)carbonyl]amino]piperidine-2-carboxylic acid
4'-(2-carboxyphenylcarbamoyl)-2'-phenoxybiphenyl-4-carboxylic acid
-
IC50 is 0.0021 mM
4'-[(2-carboxycyclohexyl)carbamoyl]-2'-phenoxybiphenyl-4-carboxylic acid
4'-[(3-hydroxy-2,4-dimethyl-5-oxo-2,5-dihydrothiophen-2-yl)methyl]biphenyl-4-carboxylic acid
-
4,4'-disulfanediylbis(2,3,6-trichlorophenol)
-
-
4,4'-sulfanediyldibenzene-1,3-diol
-
-
4,4'-sulfonylbis(3-chloroaniline)
-
-
4,5-dichloro-1,2-dithiole-3-one
4,5-dichloro-3H-1,2-dithiol-3-one
4,5-dichloro-3H-1,2-dithiole-3-thione
-
-
4-(3,4-dichlorophenyl)-2-[(2E)-2-[(4-fluorophenyl)methylidene]hydrazino]-1,3-thiazole
-
-
4-(3,4-dichlorophenyl)-2-[(2E)-2-[(4-methoxyphenyl)methylidene]hydrazino]-1,3-thiazole
-
-
4-(3,4-dichlorophenyl)-2-[(2E)-2-[(4-methylphenyl)methylidene]hydrazino]-1,3-thiazole
-
-
4-(4-biphenyl-4-ylcyclohexyl)-1,3-thiazolidin-2-one
4-(4-biphenyl-4-ylcyclohexyl)-1,3-thiazolidine-2-thione
4-(4-chlorophenyl)-2-[(2E)-2-[(4-chlorophenyl)methylidene]hydrazino]-1,3-thiazole
-
-
4-(4-chlorophenyl)-2-[(2E)-2-[(4-fluorophenyl)methylidene]hydrazino]-1,3-thiazole
-
-
4-(4-chlorophenyl)-2-[(2E)-2-[(4-methoxyphenyl)methylidene]hydrazino]-1,3-thiazole
-
-
4-(4-chlorophenyl)-2-[(2E)-2-[(4-methylphenyl)methylidene]hydrazino]-1,3-thiazole
-
-
4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide
-
-
4-bromo-2-[(E)-[(4-phenyl-1,3-thiazol-2-yl)hydrazono]methyl]phenol
-
-
4-bromo-2-[(E)-[2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]hydrazinylidene]methyl]phenol
-
-
4-bromo-2-[(E)-[[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]hydrazono]methyl]phenol
-
-
4-bromo-2-[(E)-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]hydrazono]methyl]phenol
-
-
4-bromo-3-diethylsulfamoylbenzoic acid
-
-
4-bromo-3-phenoxybenzoic acid
-
-
4-bromo-N-(4-phenyl-1,3-thiazol-2-yl)benzamide
-
-
4-bromo-N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]benzamide
-
-
4-chloro-2-[(4-hydroxyphenyl)sulfonyl]phenol
-
-
4-chloro-2-[(E)-[(4-phenyl-1,3-thiazol-2-yl)hydrazono]methyl]phenol
-
-
4-chloro-2-[(E)-[[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]hydrazono]methyl]phenol
-
-
4-chloro-2-[(E)-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]hydrazono]methyl]phenol
-
-
4-chloro-N-(4-phenyl-1,3-thiazol-2-yl)benzamide
-
-
4-fluoro-2-[(E)-[[2-(4-hydroxyphenyl)ethyl]imino]methyl]phenol
-
-
4-fluoro-3-phenoxybenzoic acid
-
-
4-fluoro-N-(4-phenyl-1,3-thiazol-2-yl)benzamide
-
-
4-methylphenyl naphthalen-2-yl sulfone
-
-
4-methylphenyl phenyl sulfone
-
-
4-phenyl-5-phenylimino-[1,2,4]dithiazolidin-3-one
-
CAS-No. 5338-82-9, IC50 is 0.00078 mM
4-[(1Z)-N,2-bis(4-chlorophenyl)ethanimidoyl]benzene-1,3-diol
-
-
4-[(E)-(cyclohexylimino)methyl]benzene-1,3-diol
4-[(E)-[2-[5-(trifluoromethyl)pyridin-2-yl]hydrazinylidene]methyl]benzene-1,3-diol
-
-
4-[3-[(2-carboxycyclohexyl)carbamoyl]phenoxy]benzoic acid
5-benzyl-2-(2-bromoacetamido)thiazole-4-carboxylic acid
-
5-chloro-1,2-dithiole-3-ones
5-chloro-1,2-dithiole-3-thiones
5-chloro-4-phenyl-3H-1,2-dithiol-3-one
-
-
5-chloro-4-phenyl-[1,2]-dithiol-3-one
-
CAS-No. 2425-05-0, IC50 is 0.0019 mM
5-ethyl-4-fluoro-2-[(2-fluoropyridin-3-yl)oxy]phenol
-
-
5-hydroxy-2-phenyl-7-(2-(piperazin-1-yl)ethoxy)-4H-chromen-4-one
-
; a chrysine derivative, strong inhibition with MIC of 0.001560.00625 mg/ml, molecular docking simulation and determination of inhibitor binding structure at the active site, overview
5-hydroxy-2-phenyl-7-(2-(piperidin-1-yl)ethoxy)-4H-chromen-4-one
-
-
5-hydroxy-2-phenyl-7-(2-(pyrrolidin-1-yl)ethoxy)-4H-chromen-4-one
-
-
5-hydroxy-2-phenyl-7-(3-(2-hydroxyethylamino)propoxy)-4H-chromen-4-one
-
-
5-hydroxy-2-phenyl-7-(3-(piperazin-1-yl)propoxy)-4H-chromen-4-one
-
-
5-hydroxy-2-phenyl-7-(3-(propylamino)propoxy)-4H-chromen-4-one
-
-
5-hydroxy-2-phenyl-7-[3-(pyrrolidin-1-yl)propoxy]-2,3-dihydro-4H-chromen-4-one
-
a strong inhibitor, interacts with Escherichia coli FabH via a hydrogen bond between its 5-hydroxy group and the amino hydrogen of Asn247 and a hydrophobic interaction between the pyrrolidine moiety at the C7 position and Asn274, Ile 156, Phe157, and Met2
5-hydroxy-7-(2-(4-methylpiperazin-1-yl)ethoxy)-2-phenyl-4H-chromen-4-one
-
-
5-hydroxy-7-(3-(4-methylpiperazin-1-yl)propoxy)-2-phenyl-4H-chromen-4-one
-
-
5-[(2,6-dichlorobenzyl)oxy]-1-(4-methoxybenzyl)-1H-indole-2-carboxylic acid
-
5-[(2,6-dichlorobenzyl)oxy]-1-[(6-methyl-1,3-benzodioxol-5-yl)methyl]-1H-indole-2-carboxylic acid
-
-
5-[(2,6-dichlorobenzyl)oxy]-1-[4-(trifluoromethyl)benzyl]-1H-indole-2-carboxylic acid
an indole derivative, inhibits FabH by 98% at 0.0375 mM
5-[(2-bromobenzyl)oxy]-1-(4-methoxybenzyl)-1H-indole-2-carboxylic acid
-
5-[(2-bromobenzyl)oxy]-1-[4-(trifluoromethyl)benzyl]-1H-indole-2-carboxylic acid
an indole derivative, inhibits FabH by 80% at 0.040 mM
5-[(4-methoxybenzyl)oxy]-1-[4-(trifluoromethyl)benzyl]-1H-indole-2-carboxylic acid
-
5-[[2-fluoro-6-(trifluoromethyl)benzyl]oxy]-1-[4-(trifluoromethyl)benzyl]-1H-indole-2-carboxylic acid
-
5-[[4-(hydroxyamino)phenyl]sulfonyl]-1,3-thiazol-2-amine
-
-
6-amino-2-hydroxy-2,5-dimethylhexanamide
-
-
7-(2-(dibutylamino)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one
-
-
7-(2-(diethylamino)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one
-
-
7-(2-(dipropylamino)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one
-
-
7-(2-(propylamino)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one
-
-
7-(3-(dibutylamino)propoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one
-
-
7-(3-(diethylamino)propoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one
-
-
7-(3-(dipropylamino)propoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one
-
-
7-[(1E)-nonadec-1-en-1-yl]-3,4-dihydro-2H-1,5-benzodioxepine
-
-
acetoxyanthecotulide
-
-
acyl-[acyl-carrier protein]
-
mixed inhibition type, the enzyme is a target for fatty acid synthesis regulation by acyl-[acyl-carrier-protein], inhibitory potency increases with increasing chain length between C12 and C20
ampicillin
-
inhibition of the recombinant enzyme in transformed Mycobacterium bovis strain BCG in vivo
anthecotulide
-
-
arsenite
-
45% inhibition at 5 mM, 98% inhibition at 20 mM
benzyl (E)-2-[(4-methylphenyl)sulfanyl]ethenyl sulfone
-
-
bis(4-chlorophenyl)trisulfane
-
-
bis(4-methylphenyl)trisulfane
-
-
bis[4-(1-methylethyl)phenyl] sulfone
-
-
butyryl-[acyl-carrier protein]
-
feed-back inhibition of the enzyme via decrease in affinity for acetyl-CoA, inhibition mechanism
cerulenin
chrysine
-
i.e 1,5,7-dihydroxyflavone
Cinnamic acid
-
-
decanoyl-CoA
-
IC50 is 0.004 mM
decanoyl-[acyl-carrier protein]
-
reversible, noncompetitive inhibition versus malonyl-[acyl-carrier-protein] and uncompetitive versus acetyl-CoA, IC50 is 0.00045 mM
decyl-CoA disulfide
-
-
diphenyl sulfide
-
-
Ethionamide
-
inhibition of the recombinant enzyme in transformed Mycobacterium bovis strain BCG in vivo
ethyl (2Z)-2-[4-(benzyloxy)phenyl]-3-[(4-methylphenyl)amino]prop-2-enoate
-
displays effective FabH inhibitory activity and excellent antibacterial activity against Gram-negative Escherichia coli. Binds to FabH through two interactions: a hydrogen bond between the N-H group and the side chain carbonyl group of Gly 209 and a hydro
ethyl 4-methylpyridine-3-carboxylate
-
-
hexanoyl-[acyl-carrier protein]
-
feed-back inhibition of the enzyme via decrease in affinity for acetyl-CoA, inhibition mechanism
hydroxyanthecotulide
-
-
Isoniazid
-
inhibition of the recombinant enzyme in transformed Mycobacterium bovis strain BCG in vivo
isoxyl
-
inhibition of the recombinant enzyme in transformed Mycobacterium bovis strain BCG in vivo
kanamycin
kanamycin B
-
-
lauroyl-ACP
feedback inhibition; feedback inhibition
methyl 2-(2-bromoacetamido)-5-(3-chlorophenyl) thiazole-4-carboxylate
-
methyl 2-(2-bromoacetamido)-5-phenylthiazole-4-carboxylate
-
methyl 2-amino-5-benzylthiazole-4-carboxylate
MIC value is 240 nM
methyl 2-amino-5-methylthiazole-4-carboxylate
MIC value is 0.093 mM
methyl 4-bromo-3-hydroxybenzoate
-
-
methyl 5-benzyl-2-(2-bromoacetamido)thiazole-4-carboxylate
-
methyl-CoA disulfide
N'-[(1E,2E)-3-(2-fluorophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine 2-carbohydrazide
-
-
N'-[(1E,2E)-3-(2-fluorophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-2-carbohydrazide
-
-
N'-[(1E,2E)-3-(2-fluorophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-5-carbohydrazide
N'-[(1E,2E)-3-(2-fluorophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-6-carbohydrazide
N'-[(1E,2E)-3-(2-methoxyphenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-2-carbohydrazide
-
-
N'-[(1E,2E)-3-(2-methoxyphenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-5-carbohydrazide
N'-[(1E,2E)-3-(2-methoxyphenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-6-carbohydrazide
N'-[(1E,2E)-3-(2-nitrophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-2-carbohydrazide
-
-
N'-[(1E,2E)-3-(2-nitrophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-5-carbohydrazide
N'-[(1E,2E)-3-(2-nitrophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-6-carbohydrazide
N'-[(1E,2E)-3-(4-bromophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-2-carbohydrazide
-
-
N'-[(1E,2E)-3-(4-bromophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-5-carbohydrazide
N'-[(1E,2E)-3-(4-bromophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-6-carbohydrazide
N'-[(1E,2E)-3-(4-methoxyphenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-2-carbohydrazide
N'-[(1E,2E)-3-(4-methoxyphenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-5-carbohydrazide
N'-[(1E,2E)-3-(4-methoxyphenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-6-carbohydrazide
N'-[(1E,2E)-3-(4-nitrophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-2-carbohydrazide
N'-[(1E,2E)-3-(4-nitrophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-5-carbohydrazide
N'-[(1E,2E)-3-(4-nitrophenyl)prop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-6-carbohydrazide
N'-[(1E,2E)-3-phenylprop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-2-carbohydrazide
-
-
-
N'-[(1E,2E)-3-phenylprop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-5-carbohydrazide
N'-[(1E,2E)-3-phenylprop-2-en-1-ylidene]-2,3-dihydro-1,4-benzodioxine-6-carbohydrazide
N'-[(E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide
-
-
N'-[(E)-(3,5-dichloro-2-hydroxyphenyl)methylidene]-4-hydroxy-3-methoxybenzohydrazide
-
-
N-(3-(5-bromo-2-hydroxybenzylideneamino)propyl)-2-hydroxybenzamide
-
-
N-(3-chlorophenyl)benzenesulfonamide
-
-
N-(4-(4-bromophenyl)thiazol-2-yl)-2-(3-chlorophenyl)acetamid
-
the malonyl carboxylate forms hydrogen bonds to the backbone nitrogen of Phe304, inhibitor binding mode, overview
N-(4-phenyl-1,3-thiazol-2-yl)-5,8-dihydronaphthalene-2-carboxamide
-
-
N-(4-phenyl-1,3-thiazol-2-yl)benzamide
N-(4-phenyl-1,3-thiazol-2-yl)morpholine-4-carboxamide
-
-
N-(4-phenyl-1,3-thiazol-2-yl)naphthalene-1-carboxamide
-
-
N-(4-phenyl-1,3-thiazol-2-yl)naphthalene-2-carboxamide
-
-
N-(4-[[4-(acetylamino)phenyl]sulfonyl]phenyl)-2-hydroxybenzamide
-
-
N-ethylmaleimide
-
complete inhibition at 5 mM
N-[3,5-bis(trifluoromethyl)phenyl]-4-[[3,5-bis(trifluoromethyl)phenyl]amino]-3-nitrocyclopenta-1,3-diene-1-sulfonamide
-
-
N-[3-[(E)-(5-bromo-2-hydroxybenzylidene)amino]propyl]-2-hydroxybenzamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(3,4-diethoxyphenyl)acetamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(3-methoxyphenyl)acetamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(4-chlorophenyl)acetamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(4-fluorophenyl)acetamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-phenylacetamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-chlorobenzamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-ethoxybenzamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-methoxybenzamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-4-chlorobenzamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-4-fluorobenzamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-5,8-dihydronaphthalene-2-carboxamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]benzamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]morpholine-4-carboxamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]naphthalene-1-carboxamide
-
-
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]naphthalene-2-carboxamide
-
-
naringenin
-
naringenin docks more strongly with efKAS III than apigenin, resulting in the intensive hydrogen bond network between naringenin and efKAS III. Only naringenin shows antibacterial activity against Enterococcus faecalis at 0.256 mg/ml
octanoyl-[acyl-carrier protein]
-
feed-back inhibition of the enzyme via decrease in affinity for acetyl-CoA, inhibition mechanism
octyl-CoA disulfide
-
-
penicillin G
platencin
platensimycin
pyridin-4-yloxybenzoic acid
-
-
rifampicin
-
inhibition of the recombinant enzyme in transformed Mycobacterium bovis strain BCG in vivo
S-[2-(4-methoxyphenyl)-2-oxoethyl] benzenesulfonothioate
-
-
SB-418011
-
-
SB418011
-
potent inhibition, the IC50 is 16 nM
secnidazole
-
-
thiolactomycin
additional information
-